Public Citizen has been assessing the quality and efficacy of drugs and devices since its founding in 1971. We use the law, petitions, and letters to monitor the FDA and coax the agency into action. Our actions have contributed to many drugs being pulled off the market. Public Citizen has also been instrumental in getting “black box” and other warnings on drugs. Our advocacy work on this drug is available below.
If you are interesting in reading our evaluations of the safety and efficacy of medications as well as information on drug side effects and interactions, please visit WorstPills.org.
More Information on blood substitutes
- Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death Meta-analysis Published in JAMA, April 28, 2008
- Study Finds New Blood Substitutes Increase Risk of Death, Heart Attacks; Authors Question FDA’s Approval Process, Records Access, April 28, 2008
- Testimony Concerning Protocol for Biopure’s Blood Sub HBOC-201, December 14, 2006
- Testing Risky Blood Substitute on Unconscious Trauma Victims Would Be Unethical, Public Citizen Tells FDA, December 14, 2006
- Public Citizen Sues FDA Over Secrecy on Blood Substitute Meeting, July 13, 2006
- Sidney Wolfe v. FDA (Seeking to open up an FDA advisory committee meeting), July 12, 2006